Inhibition of Rho A/ROCK1 signaling was found to abolish the function of tumor-associated mutant p53 (mutp53) proteins by inhibiting GLUT1 translocation to the plasma membrane, consequently leading to an inhibition of glycolysis and tumorigenesis [21]. This evidence concerns the gene SLC2A1 and neoplasm.